Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Shenzhen Edge Medical / Equity Capital Markets

<ul>
<li>Edge Medical launched its Hongkong IPO aiming to raise up to HK$1,198M. The company plans to sell 27.7M shares at HK$43.24 per share.</li>
<li>Edge Medical is an advanced surgical robot company in the medical device industry, dedicated to designing, developing and manufacturing surgical robots.</li>
<li>Edge Medical’s growth momentum will gain pace eventually turning profits. We think the issue is evenly priced and investors can surely look to have a share in this growth story.</li>
</ul>


Edge Medical launched its Hongkong IPO aiming to raise up to HK$1,198M. The company plans to sell 27.7M shares at HK$43.24 per share.
Edge Medical is an advanced surgical robot company in the medical device industry, dedicated to designing, developing and manufacturing surgical robots.
Edge Medical’s growth momentum will gain pace eventually turning profits. We think the issue is evenly priced and investors can surely look to have a share in this growth story.


Edge Medical IPO: Product Mix and Pipeline Will Support Growth Momentum and Justify Valuation